U.S. markets close in 46 minutes
  • S&P 500

    3,692.17
    +106.55 (+2.97%)
     
  • Dow 30

    29,584.45
    +858.94 (+2.99%)
     
  • Nasdaq

    10,866.64
    +291.02 (+2.75%)
     
  • Russell 2000

    1,716.04
    +51.32 (+3.08%)
     
  • Crude Oil

    83.29
    +3.80 (+4.78%)
     
  • Gold

    1,706.50
    +34.50 (+2.06%)
     
  • Silver

    20.69
    +1.66 (+8.70%)
     
  • EUR/USD

    0.9812
    +0.0011 (+0.11%)
     
  • 10-Yr Bond

    3.6490
    -0.1550 (-4.07%)
     
  • GBP/USD

    1.1305
    +0.0139 (+1.24%)
     
  • USD/JPY

    144.7750
    +0.0460 (+0.03%)
     
  • BTC-USD

    19,562.47
    +257.79 (+1.34%)
     
  • CMC Crypto 200

    444.24
    +8.88 (+2.04%)
     
  • FTSE 100

    6,908.76
    +14.95 (+0.22%)
     
  • Nikkei 225

    26,215.79
    +278.58 (+1.07%)
     

Multi-lumen Central Venous Catheters More Preferred for Catheterization Owing to Flexibility & Durability Aspects, Says Fact.MR

·6 min read
FACT.MR
FACT.MR

Market Projected To Experience Profitable Growth Over The Coming Years As A Result Of Innovations In Products, Which Could Shorten The Amount Of Time And Steps Needed For Central Venous Catheterization And Make The Procedure Much More Appropriate In All Kinds Of Circumstances

United States, Rockville MD, Sept. 05, 2022 (GLOBE NEWSWIRE) -- According to a new report by Fact.MR, a market research and competitive intelligence provider, the global central venous catheters (CVCs) market is expected to reach a valuation of US$ 1.6 billion by 2026.

The market for central venous catheters is expanding as a result of an increase in the number of competent physicians & nurses and the rising preference for various treatment modalities that are both efficient and affordable. Increased research to cure nosocomial infections, better antimicrobial catheter quality, and more people using CVCs for parenteral nutrition & fluid therapy are prominent aspects boosting the sales of central venous catheters.

For Critical Insights on Central Venous Catheters Market, Request a Sample Report
https://www.factmr.com/connectus/sample?flag=S&rep_id=7645

Rising incidence of cancer, changing lifestyles, hereditary factors, and growing use of parenteral nourishment are all contributing to the growth of the CVCs market. Market growth is also being fueled by the development of minimally-invasive procedures and a rise in the number of knowledgeable workers.

Increasing acceptance and demand for antimicrobial coated catheters, along with socioeconomic reasons, including increased illness rates because of an ageing population, are key drivers for worldwide CVCs market growth.

Which Factors Could Adversely Impact Sales of Central Venous Catheters?

“High Cost of Central Venous Catheters & Presence of Alternative Vascular Access Devices”

The market would be constrained over the forecast period by certain consequences, including injury to central veins, pulmonary difficulties, cardiac problems, device malfunction, catheter-related bloodstream infections, and the growing popularity of alternative vascular access devices.

Additionally, it is anticipated that the decline in blood transfusions will impede the expansion of the global market for central venous catheters. Over the projected period, the rising number of central venous catheter recalls is projected to restrain the growth of the global central venous catheters market.

The high price of advanced catheters, however, might impede business development. A growing proportion of patients undergoing catheterization operations need innovative central venous catheters because they have chronic and cardiovascular disorders such as urine bladder, renal failure, and coronary heart disease.

However, the adoption rate of central venous catheters may decline across low-income countries as a result of the expensive catheterization operations for these disorders.

To learn more about Central Venous Catheters Market, you can get in touch with our Analyst at https://www.factmr.com/connectus/sample?flag=AE&rep_id=7645

Key Segments Covered in the Central Venous Catheters Industry Survey

  • By Design :

    • Multi-Lumen

    • Triple-Lumen

    • Double-Lumen

    • Single-Lumen

  • By Property :

    • Non-antimicrobial Coated

    • Antimicrobial Coated

  • By Application :

    • Jugular Vein

    • Femoral Vein

    • Subclavian Vein

  • By End User :

    • Hospitals

    • Ambulatory Surgical Centers

    • Others

  • By Region :

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

Winning Strategy

Market players are concentrating on introducing antimicrobial-coated catheters and increasing their R&D activities to reduce bloodstream infections. Manufacturers of central venous catheters are placing greater emphasis on investments in product quality and design to reduce hazards and guarantee patient safety.

Market participants are working to receive regulatory authority recommendations regarding the classification of central venous catheters, and this is anticipated to drive market growth substantially over the coming years.

For instance,

  • In 2020, for detection, monitoring, and analysis of the radiofrequency and energy delivery during cardiac ablation treatments, Boston Scientific Corporation introduced the DIRECTSENSE technology tool, which is implanted at the tip of a catheter.

Get Customization on Central Venous Catheters Market Report for Specific Research Solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7645

Key players in the Central Venous Catheters Market

  • Amecath

  • Medtronic Plc

  • Smiths Medical, Inc.

  • Teleflex Incorporated

  • Vygon Ltd.

  • ZOLL Medical Corporation

  • AngioDynamics Inc.

  • B. Braun Melsungen AG

  • Bactiguard AB

  • Becton, Dickinson and Company

Key Takeaways from Central Venous Catheters Market Study

  • The global CVCs market is currently valued at US$ 1.3 billion.

  • Market in Germany projected to increase at CAGR of 5% through 2026.

  • Market in Japan anticipated to rise at 4.5% CAGR over forecast period.

  • Sales of triple-lumen central venous catheters expected to increase at CAGR of 5.5% from 2022 to 2026.

Explore Fact.MR's Coverage on the Healthcare Domain-

Orthopedic Devices Market - The global orthopedic devices market is poised to grow moderately at a CAGR of 4.0% during the forecast period (2020-2026). This growth trajectory is attributed to the prevalence of a wide range of orthopedic disorders such as osteoarthritis, rheumatoid arthritis, fibromyalgia and juvenile arthritis.

High-flow Nasal Cannula Market - North America is anticipated to dominate the high-flow nasal cannula market during the forecast period. Preference for non-invasive ventilation (NIV) and continuous positive airway pressure (CPAP) devices has augmented rapidly in home care settings for patients suffering from respiratory diseases in North America.

Microscopy Devices Market - Significant growth of contract research organizations (CROs) has boosted the scope for microscopy devices. This is because all major companies are outsourcing their research and development to focus more on their core business segments and reduce other expenditures.

Medical Holography Market - The medical holography market was valued at US$ 447.8 Million in 2019 and is projected to reach a value pool US$ 3.5 Billion by 2026, registering a stellar CAGR of 34.0% throughout the forecast period. This is in response to increasing demand for medical holography imaging.

Opthalmic Drugs Market - Visual impairment is a global health concern having a negative impact on physical and mental health. The increasing patient pool of visually impaired is anticipated to boost demand for healthcare spending on ophthalmology drugs.

Advanced Wound Care Market - North America and Europe jointly dominate the global advance wound care market, capturing more than 70% of the market. Increasing prevalence of diabetic ulcers, venous disease and arterial injuries have prompted market players to establish their business operations in the North American market.

Diabetic Neuropathy Market - The peripheral neuropathy disorder segment is projected to find increased usage of diabetic neuropathy formulations. The scope for peripheral neuropathy drugs is poised to increase, as the treatment for peripheral neuropathy is currently confined on managing pain rather than regeneration of nerves.

Softgel Capsules Market - The global softgel capsules market has gained momentum and is slated to expand at a steady CAGR of 5.5% from 2021 to 2031, owing to their diverse usage in the pharmaceutical sector in treating cardio vascular, inflammatory, and other diseases.

Oral Thin Films Market - Rapid advancements in drug delivery technologies have provided a significant stimulus to the demand for oral thin films. Incorporation of key breakthroughs as biotechnology and polymerization has greatly assisted prominent manufacturers in developing highly effective product portfolios, expanding their revenue pools and attracting a huge customer base.

Platelet-Rich Plasma Market - As per Fact.MR – a market research and competitive intelligence provider- over the last 5 years, the global market for platelet-rich plasma expanded at over 10% CAGR, closing in at over US$ 400 Mn. Increasing sports injuries incidence have majorly heightened demand in recent years.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Tel: +1 (628) 251-1583
Follow Us: LinkedIn | Twitter